Goodfellow Unit Webinar: Empagliflozin for heart failure with reduced ejection fraction
Автор: Goodfellow Unit
Загружено: 2025-02-11
Просмотров: 945
Gerry Wilkins (Consultant Cardiologist) discusses Sodium-glucose co-transporter 2 (SGLT2) inhibitor empagliflozin (the only funded one In New Zealand) that is now available for patients with reduced ejection fraction.
Chapters:
00:00 Intro
01:27 Presentation - HFrEF overview
21:46 Audience Q&A
24:59 Presentation Case Study - empagliflozin
35:19 Audience Q&A
49:24 Presentation Clinical Scenarios - Practical considerations
53:35 Audience Q&A
54:46 Presentation
01:05:03 Audience Q&A
01:08:08 Outro
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: